Elevated levels of inflammatory cytokines (IL-2, IL-6, TNF-α, and IFN-γ) in ALS patients have been found to correlate with disease severity, suggesting their potential as inflammation-related biomarkers [39,40]. The gene discussed is IL2; the disease is amyotrophic lateral sclerosis.